Modulation of MAGE-D1 expression
AssigneeIsis Pharmaceuticals, Inc.
InventorsC. Frank Bennett, Nicholas M. Dean, Kenneth W. Dobie
Life of this patent
Estimating the term…
Abstract
Compounds, compositions and methods are provided for modulating the expression of MAGE-D1. The compositions comprise oligonucleotides, targeted to nucleic acid encoding MAGE-D1. Methods of using these compounds for modulation of MAGE-D1 expression and for diagnosis and treatment of disease associated with expression of MAGE-D1 are provided.
Claims24
A compound 8 to 80 nucleobases in length targeted to a nucleic acid molecule encoding MAGE-D1, wherein said compound specifically hybridizes with said nucleic acid molecule encoding MAGE-D1 (SEQ ID NO:
- 4) and inhibits the expression of MAGE-D1.
A method of screening for a modulator of MAGE-D1, the method comprising the steps of:
- a. contacting a preferred target segment of a nucleic acid molecule encoding MAGE-D1 with one or more candidate modulators of MAGE-D1, and
- b. identifying one or more modulators of MAGE-D1 expression which modulate the expression of MAGE-D1.
A diagnostic method for identifying a disease state comprising identifying the presence of MAGE-D1 in a sample using at least one of the primers comprising SEQ ID NOs 5 or 6, or the probe comprising SEQ ID NO:
- 7.
Dependencies are inferred from the claim text.